D.E. Shaw & Co
OCEA

D.E. Shaw & Co’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

D.E. Shaw & Co’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-524,700
Closed -$5.46M – 4955
2022
Q4 		$5.46M Hold
524,700
– – 0.01% 2016
2022
Q3 		$5.35M Hold
524,700
– – 0.01% 2014
2022
Q2 		$5.33M Buy
524,700
+74,700
+17% +$755K 0.01% 2044
2022
Q1 		$4.54M Hold
450,000
– – ﹤0.01% 2425
2021
Q4 		$4.5M Buy
+450,000
New +$4.49M ﹤0.01% 2494

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

D.E. Shaw & Co's OCEA Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 524,700 shares — an estimated $5.46M sold.

D.E. Shaw & Co first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $5.46M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • D.E. Shaw & Co reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 524,700 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $5.46M.
  • D.E. Shaw & Co first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's Ocean Biomedical, Inc. Common Stock position peaked at $5.46M in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.